The European Parliament has overwhelmingly adopted the Special Committee on Beating Cancer (BECA) report in a move that marks the first time a European institution has formally acknowledged reduced risk products could play a role in smoking cessation – with some caveats.
The parliament voted 652 in favour, 15 against and 27 abstaining during last week’s plenary session. The approved plan included “compromise amendments” on alternatives approved by 29 of 34 committee members in December.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.